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Learning and memoryThe molecular composition of the postsynaptic density is modiﬁed during synaptic plasticity, which forms
the molecular basis of learning and memory. Such changes in synaptic composition depends in part on the
intricate regulation of phosphorylation of speciﬁc proteins via different protein kinases, including a serine/
threonine kinase, cyclin-dependent kinase 5 (Cdk5). However, the mechanisms underlying the involvement
of Cdk5 in neural plasticity remain elusive. Recently, the identiﬁcation of a number of synaptic proteins as
substrates or interacting proteins with Cdk5 provides important clues on how this kinase modulates the
efﬁcacy of synaptic transmission. In this review, we summarize the recent ﬁndings to illustrate the multi-
faceted roles of Cdk5 in synaptic plasticity through affecting dendritic spine formation, ion channel
conductance, protein expression, and transcription in the postsynaptic neurons. Importantly, dysregulation of
Cdk5 has been linked to Alzheimer's disease, which involves perturbations in synaptic functions and memory
formation. Understanding the mechanisms by which Cdk5 regulates synaptic plasticity may therefore
provide important insights in the design of novel therapeutic strategies for neurodegenerative diseases.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Synaptic plasticity, in which the efﬁcacy of neurotransmission is
modulated by experience, is believed to underlie memory formation
and higher cognition in the nervous system. It involves structural and
functional modiﬁcation of the postsynaptic density by synaptic
activity, and depends on the intricate regulation of protein localiza-
tion, gene transcription, protein synthesis and protein degradation.
How this large array of different cellular events is regulated by
synaptic activity has been a central question for the study of synaptic
plasticity. One crucial means of regulating these cellular processes
involves phosphorylation of synaptic proteins by protein kinases.
The serine/threonine kinase Cdk5 and its activator p35 play
multiple roles during nervous system development [1]. Emerging
evidence suggests that they are also involved in synaptic plasticity in
mature neurons [2,3]. First, both Cdk5 and p35 are localized at
neuronal synapses as well as the neuromuscular junction [4–6].
Second, many synaptic proteins isolated from the synaptosomes of
adult brains are putative substrates of Cdk5 [7]. Finally and most
importantly, the induction of synaptic plasticity, as well as hippo-
campus-dependent spatial learning, is affected in Cdk5 and p35
transgenic and knockout mice [8].
The role of Cdk5 in synaptic plasticity and learning was initially
studied using the Cdk5 inhibitors roscovitine and butyrolactone I,
which inhibited LTP induction in the area CA1 of hippocampus and
context-dependent fear conditioning, respectively [9,10]. The signiﬁ-852 2358 2765.
ll rights reserved.cance of Cdk5 in synaptic plasticity and hippocampus-dependent
spatial learning was further demonstrated by studies using knockout
and transgenic animals. Long-term depression and spatial learning
were impaired in p35 null mice [11]. Studies on these mice and, more
recently, Cdk5 conditional knockout mice further reveal that Cdk5 is
not absolutely required for the induction and expression of LTP, but
rather plays a modulatory role by increasing the threshold for LTP
induction [12,13]. Spatial learning is enhanced in the Cdk5 conditional
knockout mice, in which the expression of Cdk5 is substantially
lowered when compared to that of wild-type animals [13]. The
increased induction threshold for LTP by Cdk5 is consistent with the
observation that expression of p35, and hence Cdk5 activity, is down-
regulated by theta burst stimulation during the induction of LTP [12].
The interpretation of the role of Cdk5 in synaptic plasticity and spatial
learning is complicated by studies revealing that transgenic mice
transiently expressing p25, which is the cleaved product of p35, also
show enhanced LTP and spatial learning [14–16]. One proposed
explanation is that p25might enhance synaptic plasticity and learning
by disrupting the interaction between Cdk5 and p35, which in turn
reduces degradation of the NR2B subunit of NMDA receptor [8].
In line with the studies on the role of Cdk5 in synaptic plasticity
and learning, numerous studies in recent years have identiﬁed novel
substrates and interacting proteins of Cdk5 in neurons, some of which
provide signiﬁcant insights into the mechanisms of how Cdk5 is
involved in modulating synaptic plasticity. We summarize below
those studies demonstrating a potential link between Cdk5-mediated
phosphorylation and the functioning of the postsynaptic compart-
ment, and in some cases how it is regulated by neuronal activity. The
activity-dependent phosphorylation by Cdk5 might underlie the
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of synaptic plasticity and homeostatic response to different stimuli
such as chronic elevation of synaptic activity or repetitive exposure to
cocaine. Potential Cdk5 substrates include pre- and postsynaptic
proteins, suggesting that Cdk5 likely regulates the functioning of both
the presynaptic terminal and the postsynaptic apparatus. Here, we
mainly focus on how Cdk5 might regulate synaptic transmission on
the postsynaptic neurons. There are excellent reviews on the
phosphorylation of presynaptic proteins by Cdk5 and its potential
role in neural plasticity [e.g. 8,17], and will not be elaborated in this
review.
2. Cdk5 and dendritic spine formation
Given the large number of cytoskeleton-binding proteins as Cdk5
substrates in neurons, it is perhaps not surprising that one potential
mechanism underlying the ability of Cdk5 to modulate synaptic
plasticity involves regulation of dendritic spine formation (Fig. 1).
Dendritic spines are specialized postsynaptic compartments where
excitatory transmission takes place, and can be modiﬁed by synaptic
activity [18]. Changes in dendritic spine morphology depend on
signaling that regulates organization of the actin cytoskeleton [19,20].
The F-actin-binding protein spinophilin, which is enriched at
dendritic spines and negatively regulates their formation [21], and
its related protein neurabin I can both be phosphorylated by Cdk5
[22,23]. The functional consequence of their phosphorylation by Cdk5
on spine formation remains to be determined.
The Rho family of small GTPases consists of important signaling
molecules that relay signals to the actin cytoskeleton in response to
extracellular stimuli [24]. We recently found that the Rho guanine
nucleotide exchange factor (GEF) ephexin1 is phosphorylated by Cdk5
and this phosphorylation is critically involved in dendritic spine
retraction in response to ephrinA1, the cognate ligand that activates
the receptor tyrosine kinase EphA4 [25]. Activated EphA4 recruits
Cdk5, phosphorylates Cdk5 at Tyr-15 and increases its kinase activity.
The active Cdk5 in turn phosphorylates ephexin1, which activates
RhoA and results in retraction of dendritic spines in response to
stimulation by ephrinA1 [25]. Notably, EphA4 was recently shown to
be required for synaptic plasticity in the amygdala [26], raising the
possibility that the EphA4–Cdk5–ephexin1 pathway may be crucial in
regulating spine density during synaptic plasticity.
Another potential candidate that mediates dendritic spine plasti-
city in response to synaptic activity is the Wiskott–Aldrich syndrome
protein (WASP)-family verprolin homologous protein 1 (WAVE1).
WAVE1 is crucial for dendritic spine formation in the striatum, as
indicated by abnormal spine formation inWAVE1 knockout mice [27].Fig. 1. Possible mechanisms underlying the effect of Cdk5 on dendritic spine elimination and
WAVE1 to trigger retraction of dendritic spines. Cdk5 also promotes the cleavage and endocy
scaffold proteins PSD-95 and SPAR. All these changes are anticipated to lead to reduced synWAVE1 regulates actin polymerization and thereby dendritic spine
formation through its interaction with the Arp2/3 complex, and that
interaction is suppressed upon phosphorylation by Cdk5 [27].
Interestingly, repetitive depolarization of hippocampal neurons
induced WAVE1 dephosphorylation at the three Cdk5 phosphoryla-
tion sites [28]. The same study also showed that WAVE1 is required in
the increased spine formation after neuronal depolarization. Since
depolarization and the subsequent activation of NMDA receptor is
required for the induction of Hebbian-LTP, these studies raise the
interesting possibility that down-regulation of Cdk5 activity and
dephosphorylation of WAVE1 may represent an important mechan-
ism underlying increased spine density observed after LTP induction.
Activation of Cdk5 does not always suppress spine formation.
Chronic exposure to cocaine induces Cdk5 activity in a subpopulation
of neurons in the nucleus accumbens in vivo, leading to phosphoryla-
tion and repression of the transcription factor MEF2, thereby
enhancing dendritic spine formation (see below). Transient expres-
sion of p25 in the forebrain of transgenic mice, which elevates Cdk5
kinase activity, also increases spine density in vivo [16]. In addition,
the tubulin-binding protein collapsing response mediator protein 1
(CRMP1) can be phosphorylated by Cdk5 at Thr-509 and Ser-522, and
the phosphorylation of CRMP1 is crucial for dendritic spine formation
in response to semaphorin3A [29]. Whether phosphorylation of
CRMP1 by Cdk5 is involved in activity-dependent regulation of
dendritic spine formation requires further investigation. Finally, we
recently found that TrkB, the receptor of the neurotrophin BDNF, can
be phosphorylated by Cdk5, which is crucial for BDNF-induced
outgrowth of dendrites in hippocampal neurons [30]. Since BDNF-
TrkB signaling is involved in the growth and maturation of dendritic
spines [31,32], it will be interesting to further explore if Cdk5 also
mediates the effect of TrkB on spine morphogenesis.
3. Cdk5 and NMDA receptor
NMDA receptor acts as the sensor for coincident pre- and
postsynaptic neuronal activity, and is therefore critical to both
Hebbian-LTP and LTD. The functional NMDA receptor is a heteromeric
complex composed of the NR1 subunit and one or more of the
regulatory NR2 subunits. Phosphorylation of NR1 and NR2 subunits
regulates channel properties and localization [33]. Cdk5 phosphor-
ylates NR2A at Ser-1232, and the NMDA-evoked current in hippo-
campal neuron is reduced by roscovitine, suggesting that the
conductance of NMDA receptor may be regulated after phosphoryla-
tion by Cdk5 [9]. This was conﬁrmed by the observation that
recombinant NMDA receptor current is increased by co-expressing
Cdk5 and p35 in HEK293 cells, and the enhancement is abolishedreduction of mEPSC. Cdk5 acts on the Rho GEF ephexin1 and the actin-binding protein
tosis of the NR2B subunit of NMDA receptors, as well as degradation of the postsynaptic
aptic transmission.
Fig. 2. Cdk5 can signal to the nucleus to regulate gene transcription. The transcription
factorsMEF2 and Stat3, and the transcriptional repressor mSds3, can be phosphorylated
by Cdk5, after which their activities are regulated. The roles of these transcription
factors in neuronal plasticity remain to be determined.
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modulate NMDA-evoked EPSC in the striatum through its effect on
dopamine release. Unlike what was observed in hippocampal
neurons, inhibition of Cdk5 activity by roscovitine enhances NMDA-
EPSC in striatal neurons by increasing the phosphorylation of NR1 at
Ser-897, and this process requires presynaptic dopamine and post-
synaptic DARPP32 [35]. Since the dopamine level is low in the
hippocampus when compared to the striatum [35], it is likely that
Cdk5 mainly acts on NR2A instead of NR1 in the hippocampus, which
will account for the reduced NMDA current by roscovitine [9].
Cleavage by speciﬁc proteases such as calpain modulates the
expression level of synaptic proteins, including the NR2B subunit of
NMDA receptor, during neural plasticity [36]. The enhanced LTP and
spatial learning observed in Cdk5 conditional knockout mice can be
attributed to reduced degradation of the NR2B subunit of NMDA
receptor [13]. NMDA induces calpain-mediated cleavage of NR2B,
which is perturbed in brain slices prepared from Cdk5 conditional
knockout mice. The resulting higher expression of NR2B reduces the
threshold of LTP induction, as indicated by the ability of NR2B-
selective inhibitor ifenprodil to block the enhanced LTP observed in
Cdk5 knockout slices [13]. This study therefore suggests that Cdk5
mainly acts on NR2B, instead of NR2A, to modulate the threshold for
LTP induction. Interestingly, the effect of Cdk5 on the cleavage of
NR2B by calpain does not depend on its kinase activity. Rather, Cdk5
forms a complex with calpain and NR2B and thereby promotes the
cleavage of NR2B [13]. Apart from calpain-mediated cleavage, Cdk5
also regulates the endocytosis of NMDA receptor via phosphorylation
of PSD-95. Inhibition of Cdk5 increases the binding of PSD-95 to the
tyrosine kinase Src, which in turn induces phosphorylation of NR2B
at Tyr-1472, and attenuates activity-induced endocytosis of NR2B
[37]. These two studies therefore collectively show that reduced
Cdk5 expression or inhibition of Cdk5 activity leads to higher
expression of surface NR2B by reducing NMDA-dependent degrada-
tion and endocytosis (Fig. 1).
The scaffolding proteins that anchor NMDA receptors to the
postsynaptic density can also be directly phosphorylated by Cdk5. For
example, PSD-95 was identiﬁed as a substrate of Cdk5, with the
phosphorylation sites located at the N-terminus of PSD-95 (Thr-19,
Ser-25, and Ser-35). Mutation of these residues to alanine resulted in
the appearance of large PSD-95 puncta in immunoﬂuorescence, which
is similarly observed in hippocampal neurons cultured from Cdk5 null
mice, suggesting that Cdk5 negatively regulates PSD-95 clustering
[38]. Finally, Cdk5 may also regulate the degradation of PSD-95 and its
interacting protein SPAR at the postsynaptic density [39,40]. Cdk5 can
therefore indirectly modulate the function of NMDA receptor through
regulating the expression of scaffold proteins.
4. Cdk5—signaling to the nucleus
While most studies on Cdk5 signaling in neurons are focused on
the ability of this kinase to regulate cytoskeleton dynamics, ion
channels, and other protein kinases and phosphatases, relatively little
was known about its role in mediating long-lasting changes in
neurons that depend on gene transcription. Emerging studies,
however, have identiﬁed various nuclear proteins as potential Cdk5
substrates (Fig. 2), thereby raising the possibility that Cdk5 is involved
in modulating transcription in the nucleus that is required in long-
term synaptic plasticity.
The involvement of Cdk5 in regulating transcription that leads to
long-lasting changes in neural plasticity is perhaps best illustrated
during chronic exposure to cocaine. Repeated cocaine treatment
induces Cdk5 activity in a subpopulation of neurons in the nucleus
accumbens via increased expression through the transcription factor
delta FosB [41,42]. Induction of Cdk5 activity leads to phosphorylation
and reduced activity of the transcription factor MEF2, which results in
the growth of dendritic spines [43–45]. Expression of constitutivelyactive MEF2 in the nucleus accumbens abolishes the increased spine
density in response to chronic cocaine treatment, and unexpectedly
enhances behavioral sensitivity to cocaine [45]. The MEF2-dependent
increase in spine density might therefore represent a compensatory
response to chronic cocaine exposure, rather than being required in
cocaine sensitization. Nonetheless, these studies clearly demonstrate
that Cdk5 can signal to the nucleus to regulate gene expression that is
essential for structural changes at the synapses, and ultimately leads
to long-lasting behavioral plasticity.
Our laboratory has identiﬁed several nuclear proteins as Cdk5
substrates, including Stat3 and mSds3 [46,47]. Stat3 is a well
established transcription factor that regulates transcription in
response to many different cytokines [48]. Cdk5 phosphorylates
Stat3 at Ser-727 in muscle after activation of ErbB receptor by
neuregulin, which enhances the DNA binding and transcription of
downstream target genes [46]. Notably, both Cdk5 and Stat3 are
implicated in the pathogenesis of Alzheimer's disease, since the
expression of β-secretase BACE1, which cleaves amyloid-β precursor
protein (APP) to generate plaque-associated Aβ, is promoted by Stat3
in a Cdk5-dependent manner [49]. Recent studies from our laboratory
found that Stat3 can also be activated by other receptor tyrosine
kinases such as EphA4 and Trk receptor [50,51]. Interestingly, all these
receptor tyrosine kinases have been shown to modulate dendritic
spine formation and synaptic plasticity [2]. It is therefore important to
examine if Stat3 is also involved in modulating synaptic functions in
mature neurons.
mSds3 is a co-repressor of mSin3-histone deacetylase (HDAC). The
repressor activity of mSds3 increases after phosphorylation at Ser-228
by Cdk5 [47]. While the stimulus that triggers this phosphorylation is
not clear, mSds3 is abundant in adult brain [47]. It is noteworthy that
synaptic activity might regulate transcription by modulation of
chromatin via acetylation and deacetylation of histone in the nucleus
[52]. With the emerging evidence for the signiﬁcance of chromatin
remodeling in learning [53], it will be of great interest to examine
whether Cdk5-mediated phosphorylation of mSds3 can be regulated
by synaptic activity in mature neurons, and to explore its signiﬁcance
in transcription-dependent long-term synaptic plasticity.
Considering the hypothesis that Cdk5 can signal to the nucleus
to modulate long-term plasticity via transcriptional regulation, one
interesting question is how Cdk5, which presumably is localized at
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One possibility is that Cdk5 and its activator p35 can be transported
retrogradely along the dendrite and translocated into the nucleus,
where Cdk5 phosphorylates its substrate such as MEF2. Nuclear
localization of Cdk5 and p35 has been reported in neurons [54], and
p35 can move into the nucleus through the nuclear import carrier
importin-beta [55]. In addition, nuclear Cdk5 activity is crucial for
neuronal apoptosis [43,56]. It is therefore plausible that neuregulin,
BDNF, or synaptic activity might regulate various transcription-
dependent processes in neurons by triggering the nuclear import of
Cdk5 and p35. Cdk5 may also regulate gene expression through p25,
which is known to be present in the nucleus and has been
implicated in synaptic plasticity. Alternatively, Cdk5 may phosphor-
ylate its substrates at the synapses, which then triggers the
retrograde movement and nuclear import of the substrates, rather
than Cdk5 itself, into the nucleus. This hypothesis is consistent with
the ﬁndings that a number of transcription factors are localized in
distal processes and synapses, and their retrograde trafﬁcking and
nuclear import is triggered by stimuli that produce long-term
synaptic plasticity [57,58].5. Conclusions and future directions
Through the identiﬁcation of different substrates for Cdk5 in
neurons, signiﬁcant progress has been made in recent years in
understanding how Cdk5 might regulate the function and expression
of postsynaptic proteins. Cdk5 phosphorylation is involved in
modulating the conductance and expression of NMDA receptors,
formation and retraction of dendritic spines, degradation of synaptic
proteins, and signaling to the nucleus tomodulate gene expression. All
these molecular changes might contribute to the altered synaptic
plasticity observed in Cdk5 or p35 knockout mice. Identiﬁcation of
more Cdk5 substrates will undoubtedly increase our understanding of
the mechanisms underlying the role of Cdk5 in synaptic plasticity. It is
equally important, however, to examine how the Cdk5 phosphoryla-
tion of various substrates is regulated in different forms of neural
plasticity. Finally, it is crucial to investigate if the resulting Cdk5-
mediated phosphorylation of different proteins is required in the
induction or expression of different forms of neural plasticity by
introducing Cdk5 phosphorylation deﬁcient or mimicking mutants
into neurons.
It is clear that the roles of Cdk5 in synaptic plasticity are multi-
faceted. For example, Cdk5-mediated phosphorylation of different
proteins can lead to opposing consequences in dendritic spine
formation, i.e. phosphorylation of WAVE1 and ephexin1 results in
the loss of dendritic spines, whereas increased spine density is
observed after phosphorylation of CRMP1 and MEF2. Similarly,
activation of Cdk5 increases the degradation of PSD-95 and SPAR,
but also reduces activity of ubiquitin ligase and its activator [59]. One
possible explanation is that different subsets of substrates are
phosphorylated by Cdk5 in response to different extracellular stimuli,
e.g. ephrinA induces spine retraction via phosphorylation of ephexin1
by Cdk5, whereas semaphorin3A triggers Cdk5-dependent phosphor-
ylation of CRMP1 that leads to spine formation. With regard to
synaptic plasticity, it is especially important to understand how Cdk5
activity is regulated upon activation of NMDA receptor. Glutamate has
been shown to induce transient activation of Cdk5, which is followed
by ubiquitin-mediated degradation of p35 and thereby down-
regulation of Cdk5 activity [12]. NMDA receptor is involved in both
LTP and LTD, which have opposite consequences in spine density [18].
If Cdk5 is indeed involved in both processes in regulating the
formation of dendritic spines, the prediction will be that Cdk5 is
differentially regulated during the induction of LTP and LTD, and
different subsets of proteins are phosphorylated, ultimately leading to
opposite changes in spine density.Acknowledgements
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